Subjects: Cost-Benefit Analysis and Treatment Outcome / Authors: Ollendorf, Daniel A., author / Titles: PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Cost-Benefit Analysis ✖ Subjects Treatment Outcome ✖ Authors Ollendorf, Daniel A., author ✖ Titles PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report ✖

1. PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report

Author(s):: Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Cunningham, Courtney, author
Pearson, Steven D., author
Kazi, Dhruv S., author
Coxson, Pamela G., author
Moran, Andrew E., author
Penko, Joanne, author
Guzman, David, author
Bibbins-Domingo, Kirsten, author
Publication:: [Boston, MA] : Institute for Clinical and Economic Review, November 24, 2015
Subject(s):: Anticholesteremic Agents -- therapeutic use
Azetidines -- therapeutic use
Enzyme Inhibitors -- therapeutic use
Hypercholesterolemia -- therapy
Hyperlipoproteinemia Type II -- prevention & control
Proprotein Convertases -- economics
Serine Endopeptidases -- economics
Cholesterol, LDL
Cost-Benefit Analysis
Decision Support Techniques
Drug Costs
Drug Resistance
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Technology Assessment, Biomedical
Treatment Outcome
Value-Based Purchasing
Humans
New England
United States